DH Enchantment Inc. (ENMI)

USD 0.01

(0.0%)

EBITDA Summary of DH Enchantment Inc.

  • DH Enchantment Inc.'s latest annual EBITDA in 2024 was -145.23 Thousand USD , up 61.39% from previous year.
  • DH Enchantment Inc.'s latest quarterly EBITDA in 2024 FY was N/A , up 61.39% from previous quarter.
  • DH Enchantment Inc. reported an annual EBITDA of -376.13 Thousand USD in 2023, up 13.36% from previous year.
  • DH Enchantment Inc. reported an annual EBITDA of -434.04 Thousand USD in 2022, down -5090.08% from previous year.
  • DH Enchantment Inc. reported a quarterly EBITDA of -99.19 Thousand USD for 2024 Q4, down -1068.24% from previous quarter.
  • DH Enchantment Inc. reported a quarterly EBITDA of -15.93 Thousand USD for 2024 Q2, up 25.47% from previous quarter.

Annual EBITDA Chart of DH Enchantment Inc. (2024 - 2020)

Historical Annual EBITDA of DH Enchantment Inc. (2024 - 2020)

Year EBITDA EBITDA Growth
2024 -145.23 Thousand USD 61.39%
2023 -376.13 Thousand USD 13.36%
2022 -434.04 Thousand USD -5090.08%
2021 8700.00 USD 0.0%
2020 - USD 0.0%

Peer EBITDA Comparison of DH Enchantment Inc.

Name EBITDA EBITDA Difference
China Medicine Corporation 13.27 Million USD 101.094%
Exlites Holdings International, Inc. -90.49 Thousand USD -60.488%
Itonis, Inc. -38.31 Thousand USD -279.092%
One Step Vending Corp. -26.55 Thousand USD -446.964%
MediPal Holdings Corporation 431.52 Million USD 100.034%
PD-Rx Pharmaceuticals, Inc. -51.41 Thousand USD -182.444%
Pharmagen, Inc. -2.89 Million USD 94.981%
Suzuken Co., Ltd. 340.78 Million USD 100.043%